SPECIAL NOTICE
A -- CONTRACT OPPORTUNITY RRPV Solicitation Summary: NextGen Vaccines: Immune Assays
- Notice Date
- 2/22/2024 9:12:10 AM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- RPP-24-04-NGVxAssays
- Response Due
- 3/18/2024 10:00:00 AM
- Archive Date
- 03/18/2024
- Point of Contact
- Rebecca Harmon
- E-Mail Address
-
rebecca.harmon@ati.org
(rebecca.harmon@ati.org)
- Description
- This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) entitled, ""NextGen Vaccines: Immune Assays"".� �The purpose of this initiative is to�establish multiparameter ICS assays to identify and quantify SARS-CoV-2-specific T-cell subsets in peripheral blood mononuclear cell (PBMC) samples.� The full RPP and information on joining the consortium can be accessed through the RRPV website at www.rrpv.org.� �
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/66d6545a2e8c48f7b73a95776bab2c9b/view)
- Place of Performance
- Address: Washington, DC, USA
- Country: USA
- Country: USA
- Record
- SN06973418-F 20240224/240222230043 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |